As of Nov 11
| -0.31 / -0.37%|
The 14 analysts offering 12-month price forecasts for Merck & Co Inc have a median target of 96.50, with a high estimate of 105.00 and a low estimate of 90.00. The median estimate represents a +15.87% increase from the last price of 83.28.
The current consensus among 16 polled investment analysts is to Buy stock in Merck & Co Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.